Pranay Marlecha
Research Subjects
Pranay Marlecha has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Chanchal Maheshwari
Karachi Medical and Dental College
2 shared publications - Lokesh Koumar Sivanandam
Sri Lakshmi Narayana Institute of Medical Sciences Puducherry India
2 shared publications - Mohammed Quader Naseer
Kaloji Narayana Rao University of Health Sciences
2 shared publications - Varsha Madamanchi
Team Erevnites, Puducherry, India
2 shared publications Akiva Rosenzveig
Sections of Clinical Cardiology and Vascular Medicine Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Cleveland Clinic , Desk J3-5 9500 Euclid Avenue, Cleveland, OH 44195, USA
1 shared publication- Aravinda Nanjundappa
Cleveland Clinic Lerner College of Medicine, Cleveland, USA
1 shared publication
Latest Publications
- Top Cited Papers
- 6 January 2026
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 33 (10) , 1746-1769
Impact of PM2.5 Exposure on Cardiovascular diseases (IPEC Study): an updated umbrella review of systematic reviews and meta-analyses
Aims: Fine particulate matter (PM2.5) is a well-recognized environmental pollutant increasingly implicated in the pathogenesis of cardiovascular disease (CVD). Whilst numerous studies have established its deleterious effects, incongruencies in the magnitude, dose–response gradients, and modifying factors across systematic reviews (SRs) and meta-analyses (MAs) have limited translational clarity. Methods and results: Per the PRISMA guidelines, we conducted an umbrella review of SRs and MAs examining the association between PM2.5 exposure and cardiovascular morbidity, mortality, or intermediate biomarkers in human populations. Searches were performed across PubMed, Scopus, Embase, Web of Science, Cochrane Library, and Google Scholar up to June 2025. The methodological quality of included reviews was appraised using AMSTAR 2 and ROBIS. Thirty-eight SRs and MAs met eligibility criteria, encompassing data from diverse geographic regions and demographic settings. Cumulative evidence demonstrates a robust association between both short- and long-term PM2.5 exposure and elevated cardiovascular risk, including myocardial infarction [relative risk (RR): 1.02, 95% confidence interval (CI): 1.01–1.03], stroke (RR: 1.011, 95% CI: 1.010–1.012), heart failure (RR: 1.018, 95% CI: 1.011–1.025), arrhythmia (RR: 1.015, 95% CI: 1.006–1.024), and cardiovascular mortality. Several reviews identified dose-dependent relationships, with increased risk observed even at PM2.5 concentrations below current WHO standards (5 µg/m3 annual mean; 15 µg/m3 24 h mean), US national air quality standards (12 µg/m3 annual mean; 35 µg/m3 24 h mean), and Indian national air quality standards (40 µg/m3 annual mean; 60 µg/m3 24 h mean), have also been associated with increased cardiovascular risk. Subgroup analyses highlighted increased susceptibility among older adults, individuals with pre-existing CVD, and populations in low- and middle-income countries. Whilst most reviews were rated as moderate-to-high quality, methodological heterogeneity in exposure assessment and under-representation of data from South Asia and sub-Saharan Africa remain key limitations. Conclusion: This umbrella review consolidates high-level evidence linking PM2.5 exposure to a broad spectrum of adverse cardiovascular outcomes. The findings underline the urgent need to tighten global air quality regulations, prioritize vulnerable populations, and advance mechanistic and regional research to inform tailored policy interventions.
- 6 January 2026
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 33 (10) , 1746-1769
Top Cited PapersImpact of PM2.5 Exposure on Cardiovascular diseases (IPEC Study): an updated umbrella review of systematic reviews and meta-analyses
Aims: Fine particulate matter (PM2.5) is a well-recognized environmental pollutant increasingly implicated in the pathogenesis of cardiovascular disease (CVD). Whilst numerous studies have established its deleterious effects, incongruencies in the magnitude, dose–response gradients, and modifying factors across systematic reviews (SRs) and meta-analyses (MAs) have limited translational clarity. Methods and results: Per the PRISMA guidelines, we conducted an umbrella review of SRs and MAs examining the association between PM2.5 exposure and cardiovascular morbidity, mortality, or intermediate biomarkers in human populations. Searches were performed across PubMed, Scopus, Embase, Web of Science, Cochrane Library, and Google Scholar up to June 2025. The methodological quality of included reviews was appraised using AMSTAR 2 and ROBIS. Thirty-eight SRs and MAs met eligibility criteria, encompassing data from diverse geographic regions and demographic settings. Cumulative evidence demonstrates a robust association between both short- and long-term PM2.5 exposure and elevated cardiovascular risk, including myocardial infarction [relative risk (RR): 1.02, 95% confidence interval (CI): 1.01–1.03], stroke (RR: 1.011, 95% CI: 1.010–1.012), heart failure (RR: 1.018, 95% CI: 1.011–1.025), arrhythmia (RR: 1.015, 95% CI: 1.006–1.024), and cardiovascular mortality. Several reviews identified dose-dependent relationships, with increased risk observed even at PM2.5 concentrations below current WHO standards (5 µg/m3 annual mean; 15 µg/m3 24 h mean), US national air quality standards (12 µg/m3 annual mean; 35 µg/m3 24 h mean), and Indian national air quality standards (40 µg/m3 annual mean; 60 µg/m3 24 h mean), have also been associated with increased cardiovascular risk. Subgroup analyses highlighted increased susceptibility among older adults, individuals with pre-existing CVD, and populations in low- and middle-income countries. Whilst most reviews were rated as moderate-to-high quality, methodological heterogeneity in exposure assessment and under-representation of data from South Asia and sub-Saharan Africa remain key limitations. Conclusion: This umbrella review consolidates high-level evidence linking PM2.5 exposure to a broad spectrum of adverse cardiovascular outcomes. The findings underline the urgent need to tighten global air quality regulations, prioritize vulnerable populations, and advance mechanistic and regional research to inform tailored policy interventions.
- Open Access
- 1 October 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 9 (10)
Pegfilgrastim (Neulasta)-induced acute aortitis: a case report
Background: Granulocyte colony-stimulating factor (G-CSF) and especially pegfilgrastim for its long-lasting effects are commonly used to lower the chances of neutropenia during chemotherapy. However, extremely rarely, it may result in large-vessel vasculitis such as aortitis which is hard to detect and manage. Case summary: A 59-year-old woman with pancreatic adenocarcinoma on pegfilgrastim developed fever and upper back pain 2 days after administration. Laboratory investigations showed elevated inflammatory markers, but microbiology and autoimmune tests were negative, including tests for tuberculosis, syphilis, and Q fever. Computed tomography (CT) imaging showing periaortic fat stranding and grade II/III FDG uptake in the ascending aorta and arch on the positron emission tomography (PET) scan aided in the diagnosis of acute aortitis. Absence of other possible aetiologies and the close temporal association to pegfilgrastim administration, a diagnosis of G-CSF-induced acute aortitis was made. A multidisciplinary team managed and monitored her conservatively without glucocorticoids, due to her comorbidities. Clinical improvement with normalization of inflammatory markers and repeat PET imaging was seen over several weeks. Discussion: Granulocyte colony-stimulating factor–induced acute aortitis is a new entity emerging, with possible fatal consequences. This case shows the importance of a thorough diagnostic workup, adept interpretation of PET/CT scans with vasculitis imaging standards, and a multidisciplinary individualized management strategy guided by ESC recommendations. Clinicians should maintain a high index of suspicion for aortitis in patients receiving G-CSF, and early use of CT and PET imaging is essential to guide management and prevent complications.
- 1 October 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 9 (10)
Open AccessPegfilgrastim (Neulasta)-induced acute aortitis: a case report
Background: Granulocyte colony-stimulating factor (G-CSF) and especially pegfilgrastim for its long-lasting effects are commonly used to lower the chances of neutropenia during chemotherapy. However, extremely rarely, it may result in large-vessel vasculitis such as aortitis which is hard to detect and manage. Case summary: A 59-year-old woman with pancreatic adenocarcinoma on pegfilgrastim developed fever and upper back pain 2 days after administration. Laboratory investigations showed elevated inflammatory markers, but microbiology and autoimmune tests were negative, including tests for tuberculosis, syphilis, and Q fever. Computed tomography (CT) imaging showing periaortic fat stranding and grade II/III FDG uptake in the ascending aorta and arch on the positron emission tomography (PET) scan aided in the diagnosis of acute aortitis. Absence of other possible aetiologies and the close temporal association to pegfilgrastim administration, a diagnosis of G-CSF-induced acute aortitis was made. A multidisciplinary team managed and monitored her conservatively without glucocorticoids, due to her comorbidities. Clinical improvement with normalization of inflammatory markers and repeat PET imaging was seen over several weeks. Discussion: Granulocyte colony-stimulating factor–induced acute aortitis is a new entity emerging, with possible fatal consequences. This case shows the importance of a thorough diagnostic workup, adept interpretation of PET/CT scans with vasculitis imaging standards, and a multidisciplinary individualized management strategy guided by ESC recommendations. Clinicians should maintain a high index of suspicion for aortitis in patients receiving G-CSF, and early use of CT and PET imaging is essential to guide management and prevent complications.
- Open Access
- 17 March 2024
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 18 (1) , 1-5
Indoxacarb poisoning causing methemoglobinemia treated with parenteral vitamin C: a case report
Introduction: This case study reports on a suicide attempt involving indoxacarb and vitamin C. Indoxacarb is a neurotoxic insecticide used in agriculture and as a flea controller in pets. Cotton, vegetables, and fruits are treated with indoxacarb, an insecticide that can be applied both indoors and outdoors. It causes skin allergies, methemoglobinemia, and hemolytic anemia. It is also attributed to allergic reactions through ingestion, inhalation, physical contact, and translaminar action. This case report highlights use of vitamin C in methemoglobinemia caused by indoxacarb poisoning. Indoxacarb poisoning has the potential to be extremely serious and even lethal. In this instance, the patient initially had no symptoms after ingesting a substance containing indoxacarb in an attempt at suicide. However, further tests revealed methemoglobinemia and low oxygen levels. Case presentation: A 28-year-old south-east Asian female patient ingested an insecticide containing 5.25% novaluron, 4.5% indoxacarb, and 25% thiamethoxam, and reported that she noticed muddy brown urine but presented with no active signs or symptoms of poisoning. Upon examination, the patient was fully conscious, alert, and hemodynamically stable, but had an oxygen saturation of 84%. Gastric lavage was performed, and blood investigations revealed a muddy-brown-colored blood sample and methemoglobin levels of 12%. The patient was treated with high-dose vitamin C and showed significant improvement, with a drop in methemoglobin levels to 1.2% and an increase in oxygen saturation to 97%. Discussion: Indoxacarb poisoning can cause severe methemoglobinemia. Vitamin C may be a useful treatment option for methemoglobinemia caused by indoxacarb, particularly in cases in which traditional treatment with methylene blue is contraindicated or not tolerated. Hence high doses of ascorbic acid, that is, vitamin C, were administered to the patient, which lowered their methemoglobin levels and improved oxygen levels without much safety concerns. Conclusion: This example emphasizes the significance of early indoxacarb poisoning detection and treatment as well as the possible advantages of utilizing ascorbic acid in the management of methemoglobinemia, and highlights the use of vitamin C in the treatment of methemoglobinemia caused by indoxacarb poisoning. Therefore, it is important for healthcare professionals to be aware of the potential for indoxacarb to cause methemoglobinemia and to consider vitamin C as a treatment option.
- 17 March 2024
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 18 (1) , 1-5
Open AccessIndoxacarb poisoning causing methemoglobinemia treated with parenteral vitamin C: a case report
Introduction: This case study reports on a suicide attempt involving indoxacarb and vitamin C. Indoxacarb is a neurotoxic insecticide used in agriculture and as a flea controller in pets. Cotton, vegetables, and fruits are treated with indoxacarb, an insecticide that can be applied both indoors and outdoors. It causes skin allergies, methemoglobinemia, and hemolytic anemia. It is also attributed to allergic reactions through ingestion, inhalation, physical contact, and translaminar action. This case report highlights use of vitamin C in methemoglobinemia caused by indoxacarb poisoning. Indoxacarb poisoning has the potential to be extremely serious and even lethal. In this instance, the patient initially had no symptoms after ingesting a substance containing indoxacarb in an attempt at suicide. However, further tests revealed methemoglobinemia and low oxygen levels. Case presentation: A 28-year-old south-east Asian female patient ingested an insecticide containing 5.25% novaluron, 4.5% indoxacarb, and 25% thiamethoxam, and reported that she noticed muddy brown urine but presented with no active signs or symptoms of poisoning. Upon examination, the patient was fully conscious, alert, and hemodynamically stable, but had an oxygen saturation of 84%. Gastric lavage was performed, and blood investigations revealed a muddy-brown-colored blood sample and methemoglobin levels of 12%. The patient was treated with high-dose vitamin C and showed significant improvement, with a drop in methemoglobin levels to 1.2% and an increase in oxygen saturation to 97%. Discussion: Indoxacarb poisoning can cause severe methemoglobinemia. Vitamin C may be a useful treatment option for methemoglobinemia caused by indoxacarb, particularly in cases in which traditional treatment with methylene blue is contraindicated or not tolerated. Hence high doses of ascorbic acid, that is, vitamin C, were administered to the patient, which lowered their methemoglobin levels and improved oxygen levels without much safety concerns. Conclusion: This example emphasizes the significance of early indoxacarb poisoning detection and treatment as well as the possible advantages of utilizing ascorbic acid in the management of methemoglobinemia, and highlights the use of vitamin C in the treatment of methemoglobinemia caused by indoxacarb poisoning. Therefore, it is important for healthcare professionals to be aware of the potential for indoxacarb to cause methemoglobinemia and to consider vitamin C as a treatment option.
- Open Access
- 12 January 2023
- Published by Wiley
INDOXACARB POISONING CAUSING METHEMOGOBINEMIA: TREATED WITH PARENTERAL VITAMIN C
Indoxacarb is a neurotoxic insecticide used in agriculture and as a flea controller in pets. Causes skin allergies, methemoglobinemia, and hemolytic anemia. It is also attributed to allergic reactions through ingestion, inhalation, physical contact, and translaminar action .We report a case of Indoxacarb poisoning treated with Vitamin C
- 12 January 2023
- Published by Wiley
Open AccessINDOXACARB POISONING CAUSING METHEMOGOBINEMIA: TREATED WITH PARENTERAL VITAMIN C
Indoxacarb is a neurotoxic insecticide used in agriculture and as a flea controller in pets. Causes skin allergies, methemoglobinemia, and hemolytic anemia. It is also attributed to allergic reactions through ingestion, inhalation, physical contact, and translaminar action .We report a case of Indoxacarb poisoning treated with Vitamin C